TWI537310B - Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof - Google Patents
Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof Download PDFInfo
- Publication number
- TWI537310B TWI537310B TW103142427A TW103142427A TWI537310B TW I537310 B TWI537310 B TW I537310B TW 103142427 A TW103142427 A TW 103142427A TW 103142427 A TW103142427 A TW 103142427A TW I537310 B TWI537310 B TW I537310B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- integer
- hydrophobic
- gel composition
- hydrophobic gel
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/049—Contact lenses having special fitting or structural features achieved by special materials or material structures
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Eyeglasses (AREA)
Description
本發明係關於一種矽水膠組成物,特別是關於一種阻隔紫外光的矽水膠組成物及包含其之矽水膠鏡片。 The present invention relates to a hydrophobic gel composition, and more particularly to a hydrophobic gel composition that blocks ultraviolet light and a hydrophobic gel lens comprising the same.
由於矽水膠(silicone hydrogel)製成之隱形眼鏡鏡片(contact lens)具有高度透氧性,矽水膠鏡片可以讓充分的氧氣能直接穿過鏡片接觸角膜,使角膜有足夠的含氧量,即使長時間配戴,也較不易因角膜缺氧而造成眼睛不適的症狀。因此,矽水膠已成為隱形眼鏡鏡片較佳的成分之一。 Since the contact lens made of silicone hydrogel is highly oxygen permeable, the hydrophobic gel lens allows sufficient oxygen to pass directly through the lens to contact the cornea, so that the cornea has sufficient oxygen content. Even if worn for a long time, it is less likely to cause symptoms of eye discomfort due to corneal hypoxia. Therefore, hydrophobic glue has become one of the preferred components of contact lens lenses.
另一方面,太陽光容易造成人類眼部的傷害,尤其是造成白內障及黃斑部病變等產生視力退化的眼部疾病。在太陽光中,對人類眼部傷害最大的光波段包含長波紫外光(UVA)及近紫外光(UVB),此二光波段涵蓋了285~380奈米的波長範圍。 On the other hand, sunlight is likely to cause damage to the human eye, especially eye diseases that cause vision loss such as cataracts and macular lesions. In sunlight, the most harmful light to human eyes is long-wave ultraviolet (UVA) and near-ultraviolet (UVB), which cover the wavelength range of 285-380 nm.
上述紫外光已知會經由產生鏡片及視網膜的化學變化對於眼部造成傷害。因此,為了減少紫外光對於眼部 傷害,用於保護眼部的光學裝置(特別是太陽眼鏡)已長期且廣泛的被使用。在醫藥裝置領域中,結合隔絕紫外光化合物的眼內鏡片(intraocular lens)被認為能達到隔絕紫外光的最佳效果。此鏡片係在加熱條件下經由可聚合的隔絕紫外光單體與鏡片共聚合而成。舉例來說,美國專利第4,528,311號、第4,716,234號、第4,719,248號及第4,803,254號提出以苯並三唑(benzotriazole)或二苯基甲酮(benzophenone)做為在鏡片材料隔絕紫外光的紫外光隔絕單體。 The above ultraviolet light is known to cause damage to the eye via chemical changes that produce the lens and the retina. Therefore, in order to reduce ultraviolet light for the eye Injury, optical devices (especially sunglasses) used to protect the eyes have been used for a long time and widely. In the field of medical devices, an intraocular lens combined with an ultraviolet light-blocking compound is considered to achieve the best effect of isolating ultraviolet light. The lens is formed by copolymerization of a lens with a lens through a polymerizable ultraviolet light-absorbing monomer under heating. For example, U.S. Patent Nos. 4,528,311, 4,716,234, 4,719,248, and 4,803,254, the disclosure of which is incorporated herein by reference to benzotriazole or benzophenone as ultraviolet light for isolating ultraviolet light from lens materials. Insulate monomer.
將不親水之含矽原料製成鏡片表面親水之矽水膠鏡片相當不容易,更不用說在含矽原料中加入疏水性的紫外光隔絕單體製成鏡片表面親水之矽水膠鏡片。因此,如何使矽水膠鏡片具備良好的隔絕紫外光功效又具良好的親水性是目前仍然是亟需解決的課題。 It is not easy to make the non-hydrophilic cerium-containing raw material into a water-repellent lens which is hydrophilic on the surface of the lens, not to mention the hydrophobic ultraviolet light-insulating monomer added to the cerium-containing raw material to form a hydrophilic water-repellent lens on the surface of the lens. Therefore, how to make the hydrophobic plastic lens have good ultraviolet light-insulating effect and good hydrophilicity is still an urgent problem to be solved.
有鑑於現有技術所面臨的問題,本發明揭露一種新穎的隔絕紫外光的矽水膠組成物,其所製成之矽水膠鏡片於使用中仍持續維持有高保濕度及高度隔絕紫外光的功效。 In view of the problems faced by the prior art, the present invention discloses a novel ultraviolet light-blocking hydrophobic gel composition, which is manufactured by using the hydrophobic gel lens to maintain high moisture retention and high ultraviolet light isolation during use. efficacy.
本發明之一態樣在於提供一種阻隔紫外光的矽水膠組成物。此矽水膠組成物包含親水矽膠高聚物、阻隔紫外光單體、第一親水性單體、交聯劑及聚合反應起始劑。 One aspect of the present invention is to provide a hydrophobic gel composition that blocks ultraviolet light. The hydrophobic gel composition comprises a hydrophilic silicone polymer, a UV blocking monomer, a first hydrophilic monomer, a crosslinking agent, and a polymerization initiator.
親水矽膠高聚物佔矽水膠組成物總重量之含量為25~55wt%,且具有如通式(1)所示之化學結構: V-L-S-(L’-V’)x (1)其中,V及V’分別獨立為一乙烯基可聚合基團(ethylenically-based polymerizable group);L及L’分別獨立為一共價鍵或一鍵結基團;S為一矽氧烷基團,其為或,其中R1為一C1~C12烷基,R2為-(CH2)b-O-(CH2)c-或一C3~C6烷基,其中b為2~4之整數、及c為2~4之整數,R3為氫或甲基,W為、、或*-CH2O(CH2CH2O)f-CH2CH2OCH3,其中R4為一C1~C4烷基、R5為一C1~C2烷基、R6為一C1~C3烷基、d為2~4之整數、e為2~4之整數、f為1~20之整數、及*為通式(1)中的鍵結位置,p為10~50之整數,q為0~25之整數,m為50~100之整數,及n為4~50之整數;及x為0或1。 The hydrophilic silicone polymer comprises 25 to 55 wt% of the total weight of the hydrogel composition, and has a chemical structure as shown in the general formula (1): VLS-(L'-V') x (1) wherein V and V' are each independently an ethylenically-based polymerizable group; L and L' are each independently a covalent bond or a bonded group; S is an alkoxyalkyl group, which is or Wherein R 1 is a C1 to C12 alkyl group, R 2 is -(CH 2 ) b -O-(CH 2 ) c - or a C3 to C6 alkyl group, wherein b is an integer from 2 to 4, and c is An integer from 2 to 4, R 3 is hydrogen or methyl, and W is , , Or *-CH 2 O(CH 2 CH 2 O) f -CH 2 CH 2 OCH 3 , wherein R 4 is a C1 to C4 alkyl group, R 5 is a C1 to C2 alkyl group, and R 6 is a C1 to C3 group. An alkyl group, d is an integer of 2 to 4, e is an integer of 2 to 4, f is an integer of 1 to 20, and * is a bonding position in the formula (1), and p is an integer of 10 to 50, q An integer from 0 to 25, m is an integer from 50 to 100, and n is an integer from 4 to 50; and x is 0 or 1.
阻隔紫外光單體佔矽水膠組成物總重量之含量為0.5~2wt%。第一親水性單體佔矽水膠組成物總重量之含量為30~60wt%。交聯劑佔矽水膠組成物總重量之含量為0.2~2wt%。聚合反應起始劑佔矽水膠組成物總重量之含量為0.2~1wt%。 The content of the blocking ultraviolet light monomer in the total weight of the hydrophobic rubber composition is 0.5 to 2 wt%. The content of the first hydrophilic monomer in the total weight of the hydrophobic gel composition is 30 to 60% by weight. The content of the crosslinking agent in the total weight of the hydrophobic rubber composition is 0.2 to 2% by weight. The polymerization initiator accounts for 0.2 to 1% by weight based on the total weight of the hydrophobic rubber composition.
根據本發明之實施例,上述親水矽膠高聚物具有如通式(2)所示之化學結構:
根據本發明之實施例,上述通式(2)之L3為直接連接Y及R2的共價鍵,且q為1~25之整數。 According to an embodiment of the present invention, L 3 of the above formula (2) is a covalent bond directly linking Y and R 2 , and q is an integer of from 1 to 25.
根據本發明之實施例,上述親水矽膠高聚物具有如通式(3)所示之化學結構:
根據本發明之實施例,上述親水矽膠高聚物中的該乙烯基可聚合基團係選自由乙烯基丙烯酸酯基團(ethylenically-based acrylate)、乙烯基甲基丙烯酸酯基團(ethylenically-based methacrylate)、乙烯基丙烯醯胺基團(ethylenically-based acrylamide)、乙烯基甲基丙烯醯胺基團 (ethylenically-based methacrylamide)、乙烯基苯乙烯基團(ethylenically-based styrene)及乙烯基胺甲酸酯基團(ethylenically-based vinylcarbamate)所組成之群組。 According to an embodiment of the present invention, the vinyl polymerizable group in the hydrophilic silicone polymer is selected from the group consisting of an ethylenically-based acrylate, a vinyl methacrylate group (ethylenically-based) Methacrylate), ethylenically-based acrylamide, vinyl methacrylamide group A group consisting of ethylenically-based methacrylamide, ethylenically-based styrene, and ethylenically-based vinylcarbamate.
根據本發明之實施例,上述親水矽膠高聚物中的鍵結基團具有一主鏈及一側鏈,且鍵結基團之主鏈、側鏈或其組合包含一極性官能基。 According to an embodiment of the present invention, the bonding group in the hydrophilic silicone polymer has a main chain and a side chain, and the main chain, the side chain of the bonding group or a combination thereof contains a polar functional group.
根據本發明之實施例,上述親水矽膠高聚物中的極性官能基係選自由羥基(hydroxyl)、醯胺基(amide)、胺甲酸酯(carbamate)及尿素基(urea)所組成之群組。 According to an embodiment of the present invention, the polar functional group in the hydrophilic silicone polymer is selected from the group consisting of a hydroxyl group, an amide group, a carbamate group, and a urea group. group.
根據本發明之實施例,上述親水矽膠高聚物中的矽氧烷基團具有3個以上的矽原子,且具有一親水性側鏈。 According to an embodiment of the present invention, the oxime group in the hydrophilic silicone polymer has three or more ruthenium atoms and has a hydrophilic side chain.
根據本發明之實施例,上述親水矽膠高聚物中的親水側鏈係選自由具有醯胺基(amide)、羥基(hydroxyl)、聚乙二醇(polyethylene oxide)及其組合之基團所組成之群組。 According to an embodiment of the present invention, the hydrophilic side chain in the hydrophilic silicone polymer is selected from the group consisting of a group having an amide, a hydroxyl group, a polyethylene oxide, and a combination thereof. Group of.
根據本發明之實施例,上述親水矽膠高聚物之平均分子量為300~20,000。 According to an embodiment of the present invention, the above hydrophilic silicone polymer has an average molecular weight of 300 to 20,000.
根據本發明之實施例,上述阻隔紫外光單體為一具有二苯基甲酮(benzophenone)的單體、一具有苯並三唑(benzotriazole)的單體、一具有2-羥基苯基-s-三嗪(2-hydroxyphenyl-s-triazine)的單體或其組合。 According to an embodiment of the present invention, the blocking ultraviolet light monomer is a monomer having benzophenone, a monomer having benzotriazole, and having 2-hydroxyphenyl-s. a monomer of 2-hydroxyphenyl-s-triazine or a combination thereof.
根據本發明之實施例,上述具有二苯基甲酮(benzophenone)的單體包含4-甲基丙烯醯氧基-2-羥基二苯基甲酮(4-methacryloxy-2-hydroxy benzophenone)、4-(2-丙烯醯氧基乙氧基)-2-羥基二苯基甲酮(4-(2-acryloxyethoxy- 2-hydroxy benzophenone)或其組合。 According to an embodiment of the present invention, the above monomer having benzophenone comprises 4-methacryloxy-2-hydroxybenzophenone, 4 -(2-propenyloxyethoxy)-2-hydroxydiphenyl ketone (4-(2-acryloxyethoxy-) 2-hydroxy benzophenone) or a combination thereof.
根據本發明之實施例,上述具有苯並三唑(benzotriazole)的單體係選自由2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-benzotriazole)、2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-6-氯苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-6-chloro-benzotriazole)、2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-6-甲氧基苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-6-methoxybenzotriazole)、2-[3’-t-丁基-5’-(3”-二甲基乙基矽基丙氧基)-2’-羥基苯基]-5-甲氧基苯並三唑(2-[3’-t-butyl-5’-(3”-dimethylvinylsilylpropoxy)-2’-hydroxyphenyl]-5-methoxybenzotriazole)、2-[3’-t-丁基-2’-羥基-5’-(3”-甲基丙烯醯基丙基)-5-氯苯並三唑(2-[3’-t-butyl-5’-(3”-methacryloylozypropyl)phenyl]-5-chlorobenzotriazole)、2-[2’-羥基-5’-(γ-甲基丙烯醯氧基丙氧基)-3’-t-丁基苯基]-5-甲氧基-2H-苯並三唑(2-[2’-hydroxy-5’-(γ-methacryloyloxypropoxy)-3’-tert-butylphenyl]-5-methoxy-2H-benzotriazole)及其組合所組成之群組。 According to an embodiment of the present invention, the above single system having benzotriazole is selected from the group consisting of 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-benzotriazole ( 2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-benzotriazole), 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-6-chlorobenzotriazole (2- (2-hydroxy-5-methacryloxyethylphenyl)-2H-6-chloro-benzotriazole), 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-6-methoxybenzotriene 2-(2-hydroxy-5-methacryloxyethylphenyl-2H-6-methoxybenzotriazole), 2-[3'- t -butyl-5'-(3"-dimethylethyldecylpropoxy) -2'-hydroxyphenyl]-5-methoxybenzotriazole (2-[3'- t- butyl-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole), 2-[3'- t -butyl-2'-hydroxy-5'-(3"-methylpropenylpropyl)-5-chlorobenzotriazole (2-[3'- t- butyl-) 5'-(3"-methacryloylozypropyl)phenyl]-5-chlorobenzotriazole), 2-[2'-hydroxy-5'-( γ -methylpropenyloxypropoxy)-3'- t -butylbenzene 5-[2'-hydroxy-5'-( γ- methacryloyloxypropo a group consisting of xy)-3'-tert-butylphenyl]-5-methoxy-2H-benzotriazole) and combinations thereof.
根據本發明之實施例,上述具有2-羥基苯基-s-三嗪(2-hydroxyphenyl-s-triazine)的單體為4-甲基丙烯醯氧基乙基-2-羥基苯基-s-三嗪(4-methacryloxyethyl-2-hydroxyphenyl-s-triazine)、4-丙烯醯氧基乙基-2-羥基苯基-s-三嗪(4-acryloxyethyl-2-hydroxyphenyl-s-triazine)或其組 合。 According to an embodiment of the present invention, the above monomer having 2-hydroxyphenyl-s-triazine is 4-methylpropenyloxyethyl-2-hydroxyphenyl-s - 4-methacryloxyethyl-2-hydroxyphenyl-s-triazine, 4-acryloxyethyl-2-hydroxyphenyl-s-triazine or Group Hehe.
根據本發明之實施例,上述第一親水性單體包含N-乙烯基吡咯烷酮(N-vinyl pyrrolidone,NVP)。 According to an embodiment of the invention, the first hydrophilic monomer comprises N-vinyl pyrrolidone (NVP).
根據本發明之實施例,上述交聯劑係選自由乙烯基乙二醇基二甲基丙烯酸酯(ethylene glycol dimethacrylate)、二乙烯基乙二醇基二甲基丙烯酸酯(diethylene glycol dimethacrylate)、三乙烯基乙二醇基二甲基丙烯酸酯(triethylene glycol dimethacrylate)、四乙烯基乙二醇基二甲基丙烯酸酯(tetraethylene glycol dimethacrylate)、烯丙基甲基丙烯酸酯(ally dimethacrylate)、乙烯基乙二醇基二烯丙基醚(ethylene glycol dially ether)、三乙烯基乙二醇基二烯丙基醚(triethylene glycol dially ether)、四乙烯基乙二醇基二烯丙基醚(tetraethylene glycol dially ether)、三烯丙基-s-三嗪-2,4,6(1H,3H,5H)-三酮(triallyl-s-triazine-2,4,6(1H,3H,5H)-trione)及其組合所組成之群組。 According to an embodiment of the present invention, the crosslinking agent is selected from the group consisting of ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, and three Triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, ally dimethacrylate, vinyl B Ethylene glycol dially ether, triethylene glycol dially ether, tetraethylene glycol dially ether Ether), triallyl-s-triazine-2,4,6(1H,3H,5H)-trione (triallyl-s-triazine-2,4,6(1H,3H,5H)-trione) And the group consisting of its combination.
根據本發明之實施例,上述聚合反應起始劑為光起始劑。 According to an embodiment of the present invention, the above polymerization initiator is a photoinitiator.
根據本發明之實施例,上述光起始劑為膦氧化物起始劑(phosphine-oxide-based initiator)、茂金屬鈦化合物起始劑(titanium metallocene-based initiator)或其組合。 According to an embodiment of the invention, the photoinitiator is a phosphine-oxide-based initiator, a titanium metallocene-based initiator, or a combination thereof.
根據本發明之實施例,上述膦氧化物起始劑係選自由二苯基(2,4,6-三苯基)膦氧化物(diphenyl(2,4,6-triphenyl)phosphine oxide)、雙(2,4,6-三甲基苯甲醯 基)-苯基膦氧化物(bis(2,4,6-trimethylbenzoyl)phenyl phosphine oxide)、雙(2,6-二甲氧基苯甲醯基)(2,4,4-三甲基戊基)膦氧化物(bis(2,6-dimethoxylbenzoyl)(2,4,4-trimethylpentyl)phosphine oxide)及其組合所組成之群組。 According to an embodiment of the present invention, the above phosphine oxide initiator is selected from the group consisting of diphenyl (2,4,6-triphenyl)phosphine oxide, double (2,4,6-trimethylbenzhydrazide Bis(2,4,6-trimethylbenzoyl)phenyl phosphine oxide, bis(2,6-dimethoxybenzylidene) (2,4,4-trimethylpentene) Group of bis(2,6-dimethoxylbenzoyl(2,4,4-trimethylpentyl)phosphine oxide) and combinations thereof.
根據本發明之實施例,上述茂金屬鈦化合物起始劑包含二茂雙[2,4-二氟-3-(1-吡咯)苯基]鈦(dicyclopentadienyl bis[2,4-difluoro-3-(1-pyrrolyl)phenyl]titanium)。 According to an embodiment of the present invention, the above metallocene titanium compound initiator comprises dicyclopentadienyl bis [2,4-difluoro-3- (1-pyrrolyl)phenyl]titanium).
根據本發明之實施例,上述矽水膠組成物更包含矽氧烷單體,其佔矽水膠組成物總重量之含量為5~25wt%。 According to an embodiment of the present invention, the hydrophobic composition further comprises a siloxane monomer in an amount of 5 to 25 wt% based on the total weight of the hydrophobic composition.
根據本發明之實施例,上述矽氧烷單體包含(3-甲基丙烯醯氧基-2-羥基)丙基-雙(三甲基矽氧基)甲矽烷(3-methacryloxy-2-hydroxy)propyl-bis(trimethyl-siloxy)methylsilane)、(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基-雙(三甲基矽氧基)甲矽烷(3-methacryloxy-2-hydroxypropoxy)propyl-bis(trimethyl-siloxy)methylsilane)或其組合。 According to an embodiment of the present invention, the above methoxyxane monomer comprises (3-methacryloxy-2-hydroxy)propyl-bis(trimethyldecyloxy)methane (3-methacryloxy-2-hydroxy) Propyl-bis(trimethyl-siloxy)methylsilane), (3-methacryloxy-2-hydroxypropoxy)propyl-bis(trimethyldecyloxy)methane (3-methacryloxy-2- Hydroxypropoxy)propyl-bis(trimethyl-siloxy)methylsilane) or a combination thereof.
根據本發明之實施例,上述矽水膠組成物更包含第二親水性單體,其佔矽水膠組成物總重量之含量為5~15wt%。 According to an embodiment of the present invention, the hydrophobic composition further comprises a second hydrophilic monomer in an amount of 5 to 15% by weight based on the total weight of the hydrophobic composition.
根據本發明之實施例,上述第二親水性單體係選自由2-羥基乙基甲基丙烯酸酯(2-hydroxyethyl methacrylate)、甘油甲基丙烯酸酯(glyceryl methacrylate)、甲基丙烯酸(methacrylic acid)、丙烯酸(acrylic acid)、N,N-二甲基丙烯醯胺(N,N-dimethyl acrylamide)、N,N-二甲基甲 基丙烯醯胺(N,N-dimethyl methacrylamide)、N-乙基-N-甲基乙醯胺(N-vinyl-N-methyl acetamide)及其組合所組成之群組。 According to an embodiment of the present invention, the second hydrophilic single system is selected from the group consisting of 2-hydroxyethyl methacrylate, glyceryl methacrylate, and methacrylic acid. ,acrylic acid, N,N-dimethyl acrylamide, N,N-dimethyl A group consisting of N,N-dimethyl methacrylamide, N-vinyl-N-methyl acetamide, and combinations thereof.
本發明之一態樣在於提供一種阻隔紫外光的矽水膠鏡片。此阻隔紫外光的矽水膠鏡片包含鏡片主體,其係由上述的矽水膠組成物所構成。 One aspect of the present invention is to provide a hydrophobic gel lens that blocks ultraviolet light. The UV-blocking hydrophobic gel lens comprises a lens body composed of the above-described hydrophobic gel composition.
接著以實施例並配合圖式以詳細說明本發明,在圖式或描述中,相似或相同的部分係使用相同之符號或編號。在圖式中,實施例之形狀或厚度可能擴大,以簡化或方便標示,而圖式中元件之部分將以文字描述之。可瞭解的是,未繪示或未描述之元件可為熟習該項技藝者所知之各種樣式。 The invention will be described in detail by way of example and with reference to the accompanying drawings In the drawings, the shape or thickness of the embodiments may be expanded to simplify or facilitate the labeling, and the parts of the elements in the drawings will be described in the text. It will be appreciated that elements not shown or described may be in a variety of styles known to those skilled in the art.
本文所使用之術語僅是用於描述特定實施例之目的且不意欲限制本發明。如本文所使用,單數形式"一"(a、an)及"該"(the)意欲亦包括複數形式,除非本文另有清楚地指示。應進一步瞭解,當在本說明書中使用時,術語"包含"(comprises及/或comprising)指定存在所述之特徵、整數、步驟、運作、元件及/或組份,但並不排除存在或添加一或多個其他特徵、整數、步驟、運作、元件、組份及/或其群 組。本文參照為本發明之理想化實施例(及中間結構)之示意性說明的橫截面說明來描述本發明之實施例。如此,吾人將預期偏離該等說明之形狀之由於(例如)製造技術及/或容差的改變。因此,不應將本發明之實施例理解為限於本文所說明之特定區域形狀,而將包括起因於(例如)製造之形狀改變,且該等圖中所說明之區域本質上為示意性的,且其形狀不意欲說明設備之區域的實際形狀且不意欲限制本發明之範疇。 The terminology used herein is for the purpose of describing particular embodiments and is not intended to The singular forms "a", "the", "the" and "the" It is to be understood that the term "comprises" and / or "comprising" when used in the specification is intended to mean the presence of the described features, integers, steps, operations, components and/or components, but does not exclude the presence or addition. One or more other features, integers, steps, operations, components, components, and/or groups thereof group. Embodiments of the present invention are described herein with reference to cross-section illustrations of the schematic illustration of the preferred embodiments (and intermediate structures) of the invention. As such, it is contemplated that the shapes of the descriptions may be varied, for example, from variations in manufacturing techniques and/or tolerances. Therefore, the embodiments of the invention should not be construed as being limited to the particular shapes of the embodiments described herein. The shapes of the devices are not intended to limit the actual shape of the device and are not intended to limit the scope of the invention.
由於高透氧性和高潤濕性,矽水膠鏡片已在專業護眼領域被廣泛的接受,不但深受消費者喜愛的鏡片選擇,更成為他們的視力矯正的需求之一。目前,矽水凝鏡片已佔有50%的市佔率。然而,無論矽水膠鏡片是如此成功,矽水膠鏡片仍然被認為難以製造,且只有少數的矽水膠鏡片被認為穿戴舒適。其中,開發矽水膠鏡片最困難的部分在於一種有機矽水膠鏡片的表面潤濕特性。由於本身的疏水特性,使得矽膠材料非常難以製成具有濕潤性的鏡片,且足夠方便為使用者成功配戴。較差的潤濕性會引起大量脂肪類物質的堆積,不僅傷害視力,也使得配戴鏡片時非常不舒服。 Due to its high oxygen permeability and high wettability, hydrophobic plastic lenses have been widely accepted in the professional eye protection field. Not only are the lens choices that consumers love, but also become one of their vision correction needs. At present, 矽 water condensing lenses have a 50% market share. However, regardless of the success of hydrophobic lenses, hydrophobic lenses are still considered to be difficult to manufacture, and only a few hydrophobic lenses are considered to be comfortable to wear. Among them, the most difficult part of the development of hydrophobic gel lenses is the surface wetting characteristics of an organic hydrophobic lens. Due to its hydrophobic nature, it is very difficult to make a silicone lens with a wettable lens, and it is convenient for the user to successfully wear. Poor wetting can cause a lot of fatty substances to accumulate, which not only damages vision, but also makes it very uncomfortable when wearing lenses.
另一方面,太陽光容易造成人類眼部的傷害,尤其是造成白內障及黃斑部病變等產生視力退化的眼部疾病。在太陽光中,對人類眼部傷害最大的光波段包含長波紫外光(UVA)及近紫外光(UVB),此二光波段涵蓋了285~380奈米的波長範圍。照射過量的紫外光已知會經由產生鏡片及
視網膜的化學變化對於眼部造成傷害。因此,為了減少紫外光對於眼部傷害,用於保護眼部的光學裝置(特別是太陽眼鏡)已長期且廣泛的被使用。然而,只有極少數的矽水膠鏡片具有隔離紫外光的功效。這些鏡片大多以具有二苯基甲酮或苯並三唑官能基或具有2-羥基苯基-s-三嗪官能基隔絕紫外光單體進行修飾。二苯基甲酮、苯並三唑及2-羥基苯基-s-三嗪之結構式分別如式1、式2及式3所示:
在本發明之一實施例中,矽水膠組成物包含約1.5wt%苯並三唑類的隔絕紫外線單體(例如式4化合物)、N-乙烯基吡咯烷酮(NVP)、親水矽膠高聚物、適當的交聯劑(例如乙烯基乙二醇基二甲基丙烯酸酯(EGDMA))、含有膦氧化物的光起始劑,在光照下進行固化反應,且加工成為具有極高潤濕性的矽水膠鏡片。 In one embodiment of the invention, the hydrophobic gel composition comprises about 1.5% by weight of a benzotriazole-based UV-blocking monomer (eg, a compound of Formula 4), N-vinylpyrrolidone (NVP), a hydrophilic silicone polymer. a suitable crosslinking agent (such as vinyl glycol dimethacrylate (EGDMA)), a photoinitiator containing a phosphine oxide, undergoes a curing reaction under illumination, and is processed to have extremely high wettability. Water gel lens.
在以下具體實施方式中,將詳細且具體地說明本發 明之實施例所提供的隔絕紫外光的矽水膠組成物。此矽水膠組成物包含親水矽膠高聚物、阻隔紫外光單體、第一親水性單體、交聯劑及聚合反應起始劑。 In the following specific embodiments, the present invention will be described in detail and specifically The ultraviolet light-blocking hydrophobic gel composition provided by the examples of the present invention. The hydrophobic gel composition comprises a hydrophilic silicone polymer, a UV blocking monomer, a first hydrophilic monomer, a crosslinking agent, and a polymerization initiator.
親水矽膠高聚物佔矽水膠組成物總重量之含量為25~55wt%,且具有如通式(1)所示之化學結構:V-L-S-(L’-V’)x (1) The hydrophilic silicone polymer comprises 25 to 55 wt% of the total weight of the hydrophobic gel composition, and has a chemical structure as shown in the general formula (1): VLS-(L'-V') x (1)
在通式(1)中,V及V’分別獨立為一乙烯基可聚合基團(ethylenically-based polymerizable group)。在本發明之實施例中,乙烯基可聚合基團係選自由乙烯基丙烯酸酯基團(ethylenically-based acrylate)、乙烯基甲基丙烯酸酯基團(ethylenically-based methacrylate)、乙烯基丙烯醯胺基團(ethylenically-based acrylamide)、乙烯基甲基丙烯醯胺基團(ethylenically-based methacrylamide)、乙烯基苯乙烯基團(ethylenically-based styrene)及乙烯基胺甲酸酯基團(ethylenically-based vinylcarbamate)所組成之群組。在本發明之實施例中,V及V’可為相同或不同的乙烯基可聚合基團。 In the formula (1), V and V' are each independently an ethylenically-based polymerizable group. In an embodiment of the invention, the vinyl polymerizable group is selected from the group consisting of ethylenically-based acrylates, ethylenically-based methacrylates, vinyl acrylamides (ethylenically-based acrylamide), ethylenically-based methacrylamide, ethylenically-based styrene, and ethylenically-based Group of vinylcarbamate). In an embodiment of the invention, V and V' may be the same or different vinyl polymerizable groups.
在通式(1)中,L及L’分別獨立為一共價鍵或一鍵結基團。在本發明之實施例中,L可為直接連接V及S的共價鍵。在本發明之實施例中,L’可為直接連接V’及S的共價鍵。在本發明之實施例中,鍵結基團具有一主鏈及一側鏈,且鍵結基團之主鏈、側鏈或其組合包含一極性官能基。在本發明之實施例中,極性官能基係選自由羥基(hydroxyl)、醯胺基(amide)、胺甲酸酯(carbamate)及尿素基 (urea)所組成之群組。 In the formula (1), L and L' are each independently a covalent bond or a bond group. In an embodiment of the invention, L may be a covalent bond that directly connects V and S. In an embodiment of the invention, L' may be a covalent bond that directly connects V' and S. In an embodiment of the invention, the bonding group has a backbone and a side chain, and the backbone, side chain or combination thereof of the bonding group comprises a polar functional group. In an embodiment of the invention, the polar functional group is selected from the group consisting of a hydroxyl group, an amide, a carbamate, and a urea group. (urea) group of groups.
在通式(1)中,S為一矽氧烷基團。在本發明之實施例中,矽氧烷基團具有3個以上的矽原子,且具有一親水性側鏈。在本發明之實施例中,親水側鏈係選自由具有醯胺基(amide)、羥基(hydroxyl)、聚乙二醇(polyethylene oxide)及其組合之基團所組成之群組。 In the formula (1), S is an alkoxyalkyl group. In an embodiment of the invention, the oxoalkyl group has more than 3 germanium atoms and has a hydrophilic side chain. In an embodiment of the invention, the hydrophilic side chain is selected from the group consisting of a group having an amide, a hydroxyl group, a polyethylene oxide, and combinations thereof.
在本發明之實施例中,矽氧烷基團為
在通式(1)中,x為0或1。根據本發明之實施例,上述親水矽膠高聚物之平均分子量為300~20,000。 In the formula (1), x is 0 or 1. According to an embodiment of the present invention, the above hydrophilic silicone polymer has an average molecular weight of 300 to 20,000.
根據本發明之實施例,上述阻隔紫外光單體為一具有二苯基甲酮(benzophenone)的單體、一具有苯並三唑(benzotriazole)的單體、具有2-羥基苯基-s-三嗪(2-hydroxyphenyl-s-triazine)的單體或其組合。 According to an embodiment of the present invention, the blocking ultraviolet light monomer is a monomer having benzophenone, a monomer having benzotriazole, and having 2-hydroxyphenyl-s- Monomer of 2-hydroxyphenyl-s-triazine or a combination thereof.
根據本發明之實施例,上述具有二苯基甲酮(benzophenone)的單體包含4-甲基丙烯醯氧基-2-羥基二苯基甲酮(4-methacryloxy-2-hydroxy beuzophenone)、4-(2-丙烯醯氧基乙氧基)-2-羥基二苯基甲酮(4-(2-acryloxyethoxy-2-hydroxy benzophenone)或其組合。 According to an embodiment of the present invention, the above monomer having benzophenone comprises 4-methacryloxy-2-hydroxy benzophenone, 4 2-(2-acryloxyethoxy-2-hydroxybenzophenone) or a combination thereof.
根據本發明之實施例,上述具有苯並三唑(benzotriazole)的單體係選自由2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-benzotriazole)、2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-6-氯苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-6-chloro-benzotriazole)、2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-6-甲氧基苯並三唑(2-(2-hydroxy-5-methacryloxyethylphenyl) -2H-6-methoxybenzotriazole)、2-[3’-t-丁基-5’-(3”-二甲基乙基矽基丙氧基)-2’-羥基苯基]-5-甲氧基苯並三唑(2-[3’-t-butyl-5’-(3”-dimethylvinylsilylpropoxy)-2’-hydroxyphenyl]-5-methoxybenzotriazole)、2-[3’-t-丁基-2’-羥基-5’-(3”-甲基丙烯醯基丙基)-5-氯苯並三唑(2-[3’-t-butyl-5’-(3”-methacryloylozypropyl)phenyl]-5-chlorobenzotriazole)、2-[2’-羥基-5’-(γ-甲基丙烯醯氧基丙氧基)-3’-t-丁基苯基]-5-甲氧基-2H-苯並三唑(2-[2’-hydroxy-5’-(γ-methacryloyloxypropoxy)-3’-tert-butylphenyl]-5-methoxy-2H-benzotriazole)及其組合所組成之群組。 According to an embodiment of the present invention, the above single system having benzotriazole is selected from the group consisting of 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-benzotriazole ( 2-(2-hydroxy-5-methacryloxyethylphenyl)-2H-benzotriazole), 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-6-chlorobenzotriazole (2- (2-hydroxy-5-methacryloxyethylphenyl)-2H-6-chloro-benzotriazole), 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-6-methoxybenzotriene 2-(2-hydroxy-5-methacryloxyethylphenyl-2H-6-methoxybenzotriazole), 2-[3'- t -butyl-5'-(3"-dimethylethyldecylpropoxy) -2'-hydroxyphenyl]-5-methoxybenzotriazole (2-[3'- t- butyl-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole), 2-[3'- t -butyl-2'-hydroxy-5'-(3"-methylpropenylpropyl)-5-chlorobenzotriazole (2-[3'- t- butyl-) 5'-(3"-methacryloylozypropyl)phenyl]-5-chlorobenzotriazole), 2-[2'-hydroxy-5'-( γ -methylpropenyloxypropoxy)-3'- t -butylbenzene 5-[2'-hydroxy-5'-( γ- methacryloyloxyprop A group consisting of oxy)-3'-tert-butylphenyl]-5-methoxy-2H-benzotriazole) and combinations thereof.
根據本發明之實施例,上述具有2-羥基苯基-s-三嗪(2-hydroxyphenyl-s-triazine)的單體為4-甲基丙烯醯氧基乙基-2-羥基苯基-s-三嗪(4-methacryloxyethyl-2-hydroxyphenyl-s-triazine)、4-丙烯醯氧基乙基-2-羥基苯基-s-三嗪(4-acryloxyethyl-2-hydroxyphenyl-s-triazine)或其組合。 According to an embodiment of the present invention, the above monomer having 2-hydroxyphenyl-s-triazine is 4-methylpropenyloxyethyl-2-hydroxyphenyl-s - 4-methacryloxyethyl-2-hydroxyphenyl-s-triazine, 4-acryloxyethyl-2-hydroxyphenyl-s-triazine or Its combination.
根據本發明之實施例,上述阻隔紫外光單體佔矽水膠組成物總重量之含量為0.5~2wt%。 According to an embodiment of the present invention, the content of the ultraviolet blocking monomer alone is 0.5 to 2% by weight based on the total weight of the hydrophobic rubber composition.
根據本發明之實施例,上述第一親水性單體包含N-乙烯基吡咯烷酮(N-vinyl pyrrolidone,NVP)。根據本發明之實施例,第一親水性單體佔矽水膠組成物總重量之含量為30~60wt%。 According to an embodiment of the invention, the first hydrophilic monomer comprises N-vinyl pyrrolidone (NVP). According to an embodiment of the present invention, the first hydrophilic monomer accounts for 30 to 60% by weight based on the total weight of the hydrophobic rubber composition.
根據本發明之實施例,上述交聯劑係選自由乙烯基 乙二醇基二甲基丙烯酸酯(ethylene glycol dimethacrylate)、二乙烯基乙二醇基二甲基丙烯酸酯(diethylene glycol dimethacrylate)、三乙烯基乙二醇基二甲基丙烯酸酯(triethylene glycol dimethacrylate)、四乙烯基乙二醇基二甲基丙烯酸酯(tetraethylene glycol dimethacrylate)、烯丙基甲基丙烯酸酯(ally dimethacrylate)、乙烯基乙二醇基二烯丙基醚(ethylene glycol dially ether)、三乙烯基乙二醇基二烯丙基醚(triethylene glycol dially ether)、四乙烯基乙二醇基二烯丙基醚(tetraethylene glycol dially ether)、三烯丙基-s-三嗪-2,4,6(1H,3H,5H)-三酮(triallyl-s-triazine-2,4,6(1H,3H,5H)-trione)及其組合所組成之群組。根據本發明之實施例,上述交聯劑佔矽水膠組成物總重量之含量為0.2~2wt%。 According to an embodiment of the present invention, the crosslinking agent is selected from the group consisting of vinyl Ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate , tetraethylene glycol dimethacrylate, ally dimethacrylate, ethylene glycol dially ether, three Triethylene glycol dially ether, tetraethylene glycol dially ether, triallyl-s-triazine-2,4 , a group consisting of 6(1H,3H,5H)-trione (triallyl-s-triazine-2, 4,6(1H,3H,5H)-trione) and combinations thereof. According to an embodiment of the present invention, the crosslinking agent accounts for 0.2 to 2% by weight based on the total weight of the hydrophobic rubber composition.
根據本發明之實施例,上述聚合反應起始劑為光起始劑。根據本發明之實施例,上述光起始劑為膦氧化物起始劑(phosphine-oxide-based initiator)、茂金屬鈦化合物起始劑(titanium metallocene-based initiator)或其組合。 According to an embodiment of the present invention, the above polymerization initiator is a photoinitiator. According to an embodiment of the invention, the photoinitiator is a phosphine-oxide-based initiator, a titanium metallocene-based initiator, or a combination thereof.
根據本發明之實施例,膦氧化物起始劑係選自由二苯基(2,4,6-三苯基)膦氧化物(diphenyl(2,4,6-triphenyl)phosphine oxide)、雙(2,4,6-三甲基苯甲醯基)-苯基膦氧化物(bis(2,4,6-trimethylbenzoyl)phenyl phosphine oxide)、雙(2,6-二甲氧基苯甲醯基)(2,4,4-三甲基戊基)膦氧化物(bis(2,6-dimethoxylbenzoyl)(2,4,4-trimethylpentyl)phosphine oxide)及其組合所組成之群組。根據本發明之實施例,上 述膦氧化物起始劑的商品名包含TPO、Irgacure-403,Irgacure-819、Irgacure-1700或Irgacure-1800等類。 According to an embodiment of the present invention, the phosphine oxide initiator is selected from the group consisting of diphenyl (2,4,6-triphenyl)phosphine oxide, double (diphenyl(2,4,6-triphenyl)phosphine oxide) 2,4,6-trimethylbenzyl phenyl phosphine oxide, bis(2,6-dimethoxybenzamide) a group consisting of (2,4,4-trimethoxylbenzoyl(2,4,4-trimethylpentyl)phosphine oxide) and combinations thereof. According to an embodiment of the invention, on The trade name of the phosphine oxide starter includes TPO, Irgacure-403, Irgacure-819, Irgacure-1700 or Irgacure-1800.
根據本發明之實施例,茂金屬鈦化合物起始劑包含二茂雙[2,4-二氟-3-(1-吡咯)苯基]鈦(dicyclopentadienyl bis[2,4-difluoro-3-(1-pyrrolyl)phenyl]titanium)。根據本發明之實施例,上述茂金屬鈦化合物起始劑的商品名包含Irgacure-784等類。根據本發明之實施例,上述聚合反應起始劑佔矽水膠組成物總重量之含量為0.2~1wt%。 According to an embodiment of the present invention, the metallocene titanium compound initiator comprises dicyclopentadienyl bis[2,4-difluoro-3-(dicyclopentadienyl bis[2,4-difluoro-3-( 1-pyrrolyl)phenyl]titanium). According to an embodiment of the present invention, the trade name of the above metallocene titanium compound initiator is Irgacure-784 or the like. According to an embodiment of the present invention, the polymerization initiator is contained in an amount of from 0.2 to 1% by weight based on the total weight of the hydrophobic rubber composition.
在本發明之一實施例中,利用可見光照射矽水膠組成物,活化光起始劑,進而驅動聚合反應。 In one embodiment of the invention, the hydrophobic gel composition is irradiated with visible light to activate the photoinitiator and thereby drive the polymerization.
根據本發明之實施例,上述矽水膠組成物更包含親水性矽氧烷單體,其佔矽水膠組成物總重量之含量為5~25wt%。根據本發明之實施例,上述矽氧烷單體包含(3-甲基丙烯醯氧基-2-羥基)丙基-雙(三甲基矽氧基)甲矽烷(3-methacryloxy-2-hydroxy)propyl-bis(trimethyl-siloxy)methylsilane,如式5所示)、(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基-雙(三甲基矽氧基)甲矽烷(3-methacryloxy-2-hydroxypropoxy)propyl-bis(trimethyl-siloxy)methylsilane,如式6所示)或其組合。 According to an embodiment of the present invention, the hydrophobic composition further comprises a hydrophilic siloxane monomer in an amount of 5 to 25 wt% based on the total weight of the hydrophobic gel composition. According to an embodiment of the present invention, the above methoxyxane monomer comprises (3-methacryloxy-2-hydroxy)propyl-bis(trimethyldecyloxy)methane (3-methacryloxy-2-hydroxy) Propyl-bis(trimethyl-siloxy)methylsilane, as shown in Formula 5), (3-methacryloxy-2-hydroxypropoxy)propyl-bis(trimethyldecyloxy)methane 3-methacryloxy-2-hydroxypropoxy)propyl-bis(trimethyl-siloxy)methylsilane, as shown in Formula 6) or a combination thereof.
根據本發明之實施例,上述矽水膠組成物更包含第二親水性單體,其佔矽水膠組成物總重量之含量為5~15wt%。根據本發明之實施例,上述第二親水性單體係選自由2-羥基乙基甲基丙烯酸酯(2-hydroxyethyl methacrylate)、甘油甲基丙烯酸酯(glyceryl methacrylate)、甲基丙烯酸(methacrylic acid)、丙烯酸(acrylic acid)、N,N-二甲基丙烯醯胺(N,N-dimethyl acrylamide)、N,N-二甲基甲基丙烯醯胺(N,N-dimethyl methacrylamide)、N-乙基-N-甲基乙醯胺(N-vinyl-N-methyl acetamide)及其組合所組成之群組。 According to an embodiment of the present invention, the hydrophobic composition further comprises a second hydrophilic monomer in an amount of 5 to 15% by weight based on the total weight of the hydrophobic composition. According to an embodiment of the present invention, the second hydrophilic single system is selected from the group consisting of 2-hydroxyethyl methacrylate, glyceryl methacrylate, and methacrylic acid. ,acrylic acid, N,N-dimethyl acrylamide, N,N-dimethyl methacrylamide, N-B A group consisting of N-vinyl-N-methyl acetamide and combinations thereof.
根據本發明之實施例,第一親水矽膠高聚物具有如通式(2)所示之化學結構:
根據本發明之實施例,上述通式(2)之L3為直接連接Y及R2的共價鍵,且q為1~25之整數。 According to an embodiment of the present invention, L 3 of the above formula (2) is a covalent bond directly linking Y and R 2 , and q is an integer of from 1 to 25.
根據本發明之實施例,第二親水矽膠高聚物具有如通式(3)所示之化學結構:
根據本發明之實施例,在矽水膠組成物中可同時具有第一親水矽膠高聚物及第二親水矽膠高聚物。 According to an embodiment of the present invention, the first hydrophilic silicone polymer and the second hydrophilic silicone polymer may be simultaneously present in the hydrophobic composition.
製備一反應混合物,其包含N-乙烯基吡咯烷酮(NVP)、2-羥基乙基甲基丙烯酸酯(HEMA)、N,N-二甲基丙烯醯胺(DMA)、(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基-雙(三甲基矽氧基)甲矽烷、親水矽膠高聚物(具有如通式(2)所示之化學結構,其平均分子量為1500)、雙(2,4,6-三甲基苯甲醯基)-苯基膦氧化物、乙烯基乙二醇基二甲基丙烯酸酯、三烯丙基-s-三嗪-2,4,6(1H,3H,5H)-三酮及2-(2-羥基-5-甲基丙烯醯氧基乙基苯基)-2H-苯並三唑(相對於反應混合物總重量之 含量為1.5wt%)。 A reaction mixture comprising N-vinylpyrrolidone (NVP), 2-hydroxyethyl methacrylate (HEMA), N,N-dimethyl decylamine (DMA), (3-methacryl oxime) is prepared. Oxy-2-hydroxypropoxy)propyl-bis(trimethyldecyloxy)methane, a hydrophilic silicone polymer (having a chemical structure as shown in the formula (2), having an average molecular weight of 1,500) , bis(2,4,6-trimethylbenzylidene)-phenylphosphine oxide, vinyl glycol dimethacrylate, triallyl-s-triazine-2,4, 6(1H,3H,5H)-trione and 2-(2-hydroxy-5-methylpropenyloxyethylphenyl)-2H-benzotriazole (relative to the total weight of the reaction mixture) The content is 1.5% by weight).
上述反應混合物可於一對聚丙烯模具中,經由照射可見光進行交聯固化反應,以製造矽水膠鏡片。此矽水膠鏡片可利用乾脫除法自模具中取下。 The above reaction mixture can be cross-linked and cured by irradiation of visible light in a pair of polypropylene molds to produce a hydrophobic gel lens. The hydrophobic gel lens can be removed from the mold by dry removal.
經由異丙醇溶液萃取及水溶液清洗後,將矽水膠鏡片保存於含有硼酸食鹽水緩衝溶液的容器後,再進行滅菌步驟。 After being extracted by an isopropyl alcohol solution and washed with an aqueous solution, the hydrophobic gel lens is stored in a container containing a boric acid saline buffer solution, and then subjected to a sterilization step.
由上述製造方法所製成的矽水膠鏡片皆具有46~54wt%的含水量。在本發明之一實施例中,一矽水膠鏡片具有48wt%的含水量,其氧穿透度為101 DK及彈性模數為0.73MPa。 The hydrophobic rubber lenses produced by the above manufacturing methods all have a water content of 46 to 54% by weight. In one embodiment of the invention, a hydrogel lens has a moisture content of 48 wt%, an oxygen permeability of 101 DK and an elastic modulus of 0.73 MPa.
矽水膠鏡片的紫外光透射度係利用Cary 50紫外光/可見光光譜儀進行測量。此矽水膠鏡片的平均中心厚度為80微米,且裝置在充滿硼酸食鹽水緩衝溶液的比色皿(cuvette)中。 The UV transmittance of the hydrophobic gel lens was measured using a Cary 50 UV/Vis spectrometer. The hydrophobic gel lens had an average center thickness of 80 microns and was placed in a cuvette filled with a borate brine solution.
實施例1所製成的矽水膠鏡片之紫外光A(UVA)及紫外光B(UVB)區段的透射度如表1所示。 The transmittances of the ultraviolet A (UVA) and ultraviolet B (UVB) sections of the hydrophobic gel lens produced in Example 1 are shown in Table 1.
由表1的結果可知,實施例1所製成的矽水膠鏡片之紫外光A(UVA)及紫外光B(UVB)區段的平均透射度分別為7.78%及0.24%。此結果以符合紫外光隔離能力的第1級(Class I)標準。 From the results of Table 1, the average transmittances of the ultraviolet A (UVA) and ultraviolet B (UVB) sections of the hydrophobic gel lens produced in Example 1 were 7.78% and 0.24%, respectively. This result is in accordance with Class I standards for UV isolation.
滯後接觸角可使用熟習此項技術者已知之常規方法來測定,例如捕泡法。捕泡法為將聚矽氧水凝膠鏡片夾於兩個硬質塑膠間,使鏡片中心部分較為平坦,然後將鏡片浸入填充硼酸鹽緩衝鹽水溶液中之一凹槽。接著,將氣泡注射於鏡片表面,並停留在表面上,然後拍照並計算鏡片的左與右之接觸角,再取其平均數。 The hysteresis contact angle can be determined using conventional methods known to those skilled in the art, such as bubble trapping. The bubble trapping method is to sandwich the polyoxyl hydrogel lens between two rigid plastics so that the central portion of the lens is relatively flat, and then immersing the lens in one of the grooves filled with the borate buffered saline solution. Next, the bubble is injected onto the surface of the lens and stays on the surface, then photographed and the left and right contact angles of the lens are calculated, and the average is taken.
表2係比較實施例1所製成的矽水膠鏡片與能阻隔紫外光(I與II等級)的市售矽水膠鏡片(Senofilcon A、Narafilcon A、Galyfilcon A、Enfilcon A、Clariti(Somofilcon A))之滯後接觸角。 Table 2 compares the hydrophobic gel lenses made in Example 1 with commercially available hydrophobic gel lenses that can block ultraviolet light (Class I and II) (Senofilcon A, Narafilcon A, Galyfilcon A, Enfilcon A, Clariti (Somofilcon A). )) The lagging contact angle.
在此技術領域中,當矽水膠鏡片的滯後接觸角等於或小於15°時,此矽水膠鏡片具有相當好的潤濕性。如表2的結果所示,一般市售的矽水膠鏡片之滯後接觸角為13.3°~48.7°,而本發明之實施例1所提供的矽水膠鏡片之滯後接觸角為9°。由此可知,明顯本發明之實施例1所提供的矽水膠鏡片之潤濕性優於一般市售的矽水膠鏡片。 In this technical field, the hydrophobic rubber lens has a relatively good wettability when the hysteresis contact lens has a hysteresis contact angle of 15 or less. As shown by the results of Table 2, the hysteresis contact angle of a commercially available hydrophobic rubber lens was 13.3 to 48.7, and the hysteresis contact angle of the hydrophobic rubber lens provided in Example 1 of the present invention was 9°. From this, it is apparent that the wettability of the hydrophobic gel lens provided in Example 1 of the present invention is superior to that of a commercially available hydrophobic gel lens.
另一方面,相較於本發明之實施例1或其他三種市售矽水膠鏡片,Enfilcon A及Clariti(Somofilcon A)係利用熱固化方式進行矽水膠組成物的交聯反應,Enfilcon A及Clariti(Somofilcon A)具有較大的滯後接觸角。即使此二種鏡片(Enfilcon A及Clariti(Somofilcon A))含有較少量或阻擋紫外光較差之抗紫外光單體,由此結果足以證明熱固化方式進行矽水膠組成物的交聯反應將降低矽水膠組成物的潤濕性,造成滯後接觸角變大。 On the other hand, Enfilcon A and Clariti (Somofilcon A) use a heat curing method to carry out cross-linking reaction of the hydrophobic rubber composition compared to Example 1 of the present invention or other three commercially available hydrophobic plastic lenses, Enfilcon A and Clariti (Somofilcon A) has a large hysteresis contact angle. Even if the two lenses (Enfilcon A and Clariti (Somofilcon A)) contain less or block UV-resistant UV-resistant monomers, the results are sufficient to demonstrate that the heat-curing method of the cross-linking reaction of the hydrophobic gel composition will The wettability of the hydrophobic gel composition is lowered, resulting in a large hysteresis contact angle.
1.製備食鹽水溶液及對照組脂質食鹽水溶液:配製0.9 w/v%的食鹽水;將0.1克膽固醇(CAS編號57-88-5)溶於10克乙醇中,再加入1000毫升的0.9 w/v%的食鹽水中,其中含有1.5克鈉脫氧膽酸(sodium deoxycholate)。 1. Preparation of saline solution and control lipid aqueous salt solution: preparation 0.9 w/v% saline; 0.1 g of cholesterol (CAS No. 57-88-5) was dissolved in 10 g of ethanol, and then added to 1000 ml of 0.9 w/v% saline containing 1.5 g of sodium deoxycholate. (sodium deoxycholate).
2.測定高效能液相層析儀(HPLC)校正曲線:取0、1、2、3、4及5毫升的上述溶液,以10毫升的0.9 w/v%的食鹽水稀釋;注入HPLC中,以測定校正曲線。 2. Determination of high performance liquid chromatography (HPLC) calibration curve: Take 0, 1, 2, 3, 4 and 5 ml of the above solution, diluted with 10 ml of 0.9 w / v% saline; injected into HPLC To determine the calibration curve.
3.吸收值測試:取8片矽水膠鏡片,每片都浸置於2毫升標準脂質溶液中,於37℃的烘箱中,封存8小時。接著,取出鏡片,於2毫升的0.9 w/v%的食鹽水中,浸置30分鐘。混合上述共4毫升的溶液,且以HPLC測量其中的脂質含量。標準脂質溶液與測試溶液的濃度差可用以計算被鏡片吸附的脂質含量。 3. Absorption value test: 8 pieces of hydrophobic glue lenses were taken, each of which was immersed in 2 ml of standard lipid solution, and sealed in an oven at 37 ° C for 8 hours. Next, the lens was taken out and immersed in 2 ml of 0.9 w/v% saline for 30 minutes. A total of 4 ml of the above solution was mixed, and the lipid content therein was measured by HPLC. The difference in concentration between the standard lipid solution and the test solution can be used to calculate the lipid content adsorbed by the lens.
4.以多用途溶液(MPS)清洗鏡片:由步驟3取出鏡片,以2毫升的多用途溶液(multipurpose solution,MPS;-Bausch & Lomb的Biotrue)浸置8小時。 4. Wash the lens with a multi-purpose solution (MPS): The lens was removed from step 3 and immersed in 2 ml of multipurpose solution (MPS; - Biotrue of Bausch & Lomb) for 8 hours.
5.於第7天、第14天、第21天及第30天,重複步驟3及步驟4,所測得的鏡片中總脂質沈積量如表3所列。 5. On Days 7, 14, 21, and 30, steps 3 and 4 were repeated. The total lipid deposition in the lenses was as listed in Table 3.
6.相較於第1天的總脂質沈積量,第7天、第14天、第21天及第30天的被鏡片吸附的脂質含量差值表示無法被MPS移除的永久性沈積量,所測得的鏡片中殘餘脂質含量差值如表3所列。 6. The difference in lipid content adsorbed by the lens on days 7, 14, 21 and 30 represents the amount of permanent deposition that cannot be removed by MPS compared to the total lipid deposition on day 1. The difference in residual lipid content in the measured lenses is as listed in Table 3.
1.製備緩衝食鹽水溶液及對照組蛋白質食鹽水溶液:將10克氯化鈉、7.7克磷酸氫二鈉(十二結晶水)及0.634克磷 酸二氫鈉(二結晶水)溶解於1200毫升去離子水中,配製成pH值為7.4的緩衝食鹽水,其滲透壓為310mOsm/kg(H2O);將1.9克溶菌酶、0.2克小牛血清白蛋白及0.1克γ-球蛋白溶於1000毫升緩衝食鹽水中。 1. Preparation of buffered saline solution and control protein salt solution: 10 g of sodium chloride, 7.7 g of disodium hydrogen phosphate (d 12 crystal water) and 0.634 g of sodium dihydrogen phosphate (dicrystal water) were dissolved in 1200 ml deionized In water, it is formulated into a buffered saline solution with a pH of 7.4, and its osmotic pressure is 310 mOsm/kg (H 2 O); 1.9 g of lysozyme, 0.2 g of calf serum albumin and 0.1 g of γ-globulin are dissolved in 1000. Mg buffered in saline solution.
2.測定紫外光吸收曲線:取0.1、0.3、0.5、0.7、0.9、1.0、1.2、1.5及2.0毫升的上述蛋白質溶液,以緩衝食鹽水溶液稀釋成10毫升的溶液。測量波長為280奈米的紫外光之吸收值。 2. Measurement of ultraviolet light absorption curve: 0.1, 0.3, 0.5, 0.7, 0.9, 1.0, 1.2, 1.5 and 2.0 ml of the above protein solution were taken and diluted with a buffered saline solution into a 10 ml solution. The absorption of ultraviolet light having a wavelength of 280 nm was measured.
3.吸收值測試:取8片矽水膠鏡片,每片都浸置於2毫升標準蛋白質溶液中,於37℃的烘箱中,封存8小時。接著,取出鏡片,於2毫升的0.9 w/v%的食鹽水中,浸置30分鐘。混合上述共4毫升的溶液,且測量其紫外光吸收值。標準蛋白質溶液與測試溶液的濃度差可用以計算被鏡片吸附的蛋白質含量。 3. Absorption value test: 8 pieces of hydrophobic glue lenses were taken, each of which was immersed in 2 ml of standard protein solution and stored in an oven at 37 ° C for 8 hours. Next, the lens was taken out and immersed in 2 ml of 0.9 w/v% saline for 30 minutes. A total of 4 ml of the above solution was mixed, and the ultraviolet absorption value was measured. The difference in concentration between the standard protein solution and the test solution can be used to calculate the amount of protein adsorbed by the lens.
4.以MPS清洗鏡片:由步驟3取出鏡片,以2毫升的多用途溶液(multipurpose solution,MPS;-Bausch & Lomb的Biotrue)浸置8小時。 4. Clean the lens with MPS: The lens was removed from step 3 and immersed for 8 hours with 2 ml of multipurpose solution (MPS; - Bautrue & Lomb's Biotrue).
5.於第7天、第14天、第21天及第30天,重複步驟3及步驟4,所測得的鏡片中總蛋白質沈積量如表3所列。 5. On Days 7, 14, 21, and 30, steps 3 and 4 were repeated. The total amount of protein deposited in the lenses was as listed in Table 3.
6.相較於第1天的總蛋白質沈積量,第7天、第14天、第21天及第30天的被鏡片吸附的蛋白質含量差值表示無法被MPS移除的永久性沈積量,所測得的鏡片中殘餘蛋白質含量差值如表3所列。 6. The difference in protein content adsorbed by the lens on Days 7, 14, 21, and 30 represents the amount of permanent deposition that cannot be removed by MPS compared to the total amount of protein deposited on Day 1. The difference in residual protein content in the measured lenses is as listed in Table 3.
表3為矽水膠鏡片中脂質及蛋白質沈積 Table 3 shows lipid and protein deposition in hydrophobic gel lenses
在表3中,本發明之實施例所提供的矽水膠鏡片於第1天之總脂質沈積量為185.2微克,與市售之Senofilcon A及Comfilcon A之總脂質沈積量類似。然而,經過重複的MPS清洗及再沈積測試後,本發明之實施例所提供的矽水膠鏡片於第30天時無法移除的淨脂質差值為1.77微克,此結果明顯低於市售之Senofilcon A及Comfilcon A(分別為3.95微克及3.66微克)。由此可知,相較於市售之Senofilcon A及Comfilcon A,本發明之實施例所提供的矽水膠鏡片具有較佳的親水性。 In Table 3, the total lipid deposition amount of the hydrophobic gel lens provided by the examples of the present invention on day 1 was 185.2 micrograms, similar to the total lipid deposition amount of commercially available Senofilcon A and Comfilcon A. However, after repeated MPS cleaning and redeposition testing, the difference in net lipids that could not be removed on day 30 of the hydrophobic gel lens provided by the examples of the present invention was 1.77 micrograms, which was significantly lower than the commercially available one. Senofilcon A and Comfilcon A (3.95 μg and 3.66 μg, respectively). It can be seen that the hydrophobic gel lens provided by the embodiment of the present invention has better hydrophilicity than the commercially available Senofilcon A and Comfilcon A.
在表3中,相較於市售之Senofilcon A及Comfilcon A,本發明之實施例所提供的矽水膠鏡片有相當少量的蛋白質物質沈積(0.568微克/片),此結果表示,本發明之實施例所提供的矽水膠鏡片具有顯著的抗蛋白質沈積的效果。另一方面,本發明之實施例所提供的矽水膠鏡片之第30天後鏡片中蛋白殘餘差值為0.033微克/片,此結果高於市售之Senofilcon A及Comfilcon A(分別為0.21微克及0.25微克)。因此相較於市售之Senofilcon A及Comfilcon A,本發明之實施例所提供的矽水膠鏡片具有較佳的親水性。 In Table 3, the hydrophobic gel lens provided by the examples of the present invention has a relatively small amount of protein material deposition (0.568 μg/tablet) compared to the commercially available Senofilcon A and Comfilcon A, and the results show that the present invention The hydrophobic gel lenses provided in the examples have significant anti-protein deposition effects. On the other hand, the residual value of the protein in the lens after the 30th day of the hydrophobic gel lens provided by the embodiment of the present invention is 0.033 μg/tablet, which is higher than the commercially available Senofilcon A and Comfilcon A (0.21 μg, respectively). And 0.25 micrograms). Thus, the hydrophobic gel lenses provided by the embodiments of the present invention have better hydrophilicity than the commercially available Senofilcon A and Comfilcon A.
在本發明之實施例中,矽水膠鏡片的紫外光A(380~316nm)透射度小於10%,且紫外線B(315~285nm)透射度小於1%,此結果符合美國食品藥物管理局(FDA)對於第1類隔絕紫外線隱形眼鏡的標準。 In an embodiment of the invention, the ultraviolet light A (380-316 nm) transmittance of the hydrophobic gel lens is less than 10%, and the ultraviolet B (315-285 nm) transmittance is less than 1%, which is in accordance with the US Food and Drug Administration ( FDA) Standard for Class 1 UV-blocking contact lenses.
此外,由於矽水膠鏡片本身為疏水性材料,因此矽水膠鏡片容易吸附脂質,造成視線模糊及配戴時的不適感。本發明之實施例所提供的矽水膠鏡片的化學結構中具有親水側鏈、極性官能基或其組合,因此相較於市售隔絕紫外線隱形眼鏡,本發明之實施例所提供的矽水膠鏡片具有較佳的親水性和潤濕性,故能有效避免脂質及蛋白質的沈積。 In addition, since the hydrophobic gel lens itself is a hydrophobic material, the hydrophobic gel lens is easy to adsorb lipids, causing blurred vision and discomfort during wearing. The hydrophobic structure of the embodiment of the present invention has a hydrophilic side chain, a polar functional group or a combination thereof, and thus the hydrophobic gel provided by the embodiment of the present invention is compared with a commercially available ultraviolet shielding contact lens. The lens has better hydrophilicity and wettability, so it can effectively prevent the deposition of lipids and proteins.
雖然本發明之實施例已揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許之更動與潤飾,因此本發明之保護範圍當以後附之申請專利範圍所界定為準。 Although the embodiments of the present invention have been disclosed as above, it is not intended to limit the present invention, and any person skilled in the art can make some modifications and retouchings without departing from the spirit and scope of the present invention. The scope is defined as defined in the scope of the patent application.
Claims (24)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103142427A TWI537310B (en) | 2014-12-05 | 2014-12-05 | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
KR1020150023599A KR20160068618A (en) | 2014-12-05 | 2015-02-16 | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103142427A TWI537310B (en) | 2014-12-05 | 2014-12-05 | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI537310B true TWI537310B (en) | 2016-06-11 |
TW201620959A TW201620959A (en) | 2016-06-16 |
Family
ID=56135260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103142427A TWI537310B (en) | 2014-12-05 | 2014-12-05 | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20160068618A (en) |
TW (1) | TWI537310B (en) |
-
2014
- 2014-12-05 TW TW103142427A patent/TWI537310B/en active
-
2015
- 2015-02-16 KR KR1020150023599A patent/KR20160068618A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20160068618A (en) | 2016-06-15 |
TW201620959A (en) | 2016-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8367746B2 (en) | Silicone hydrogel contact lens | |
KR101641476B1 (en) | Ophthalmic devices for delivery of beneficial agents | |
US10723732B2 (en) | Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light | |
TW202114993A (en) | Polymerizable fused tricyclic compounds as absorbers of uv and visible light | |
US10975040B2 (en) | Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light | |
KR20220054543A (en) | Multifocal contact lenses exhibiting improved vision properties | |
KR20220054542A (en) | Contact lenses exhibiting improved vision properties | |
US9322958B2 (en) | Silicone hydrogel contact lenses | |
KR102658250B1 (en) | Oleic acid-releasing contact lenses | |
US9482788B2 (en) | UV-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
CA3121326A1 (en) | Selectively wettable and oxygen-permeable lenses | |
TWI537310B (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
US20230066936A1 (en) | Contact lens with improved tear film optical quality | |
CN105713153B (en) | Obstruct the silicon glue composition of ultraviolet light and the silicon glue eyeglass comprising it | |
RU2602815C2 (en) | Uv radiation blocking silicone-hydrogel composition and silicone-hydrogel contact lens based thereon | |
JP6149028B2 (en) | UV blocking silicone hydrogel composition and silicone hydrogel contact lens comprising the same | |
EP3173826B1 (en) | Hydrogel composition and hydrogel contact lenses made of the composition | |
EP3029081A1 (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
CA2873437C (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
RU2779564C1 (en) | Methods for manufacture of photo-absorbing contact lenses, and photo-absorbing contact lenses obtained by means of them | |
AU2014271336A1 (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
EP2650021B1 (en) | Medical device for controlled release of drug | |
NZ702728B (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
TW202426249A (en) | Ws12-releasing contact lens |